Anti-IL-17 Antibody Improves Hepatic Steatosis by Suppressing Interleukin-17-Related Fatty Acid Synthesis and Metabolism

Figure 3

Activation of a peripheral IL-17-secreting phenotype in liver tissue of every ALD group. Data are representative of three separate experiments.